Rallis India Q1 profit rises 31%; SBI Mutual Fund cuts stake to 7.12%
Tata Chemicals subsidiary Rallis India reported Q1 FY27 net profit of ₹125 crore, with total income rising to ₹1,035 crore. Separately, SBI Mutual Fund reduced its holding to 7.12% through a market sale.
What happened
SBI Mutual Fund cut its Rallis India stake to 7.12% after a market sale. Tata Chemicals subsidiary Rallis reported Q1 FY27 net profit up 31% to ₹125 crore and
Key facts
- SBI Mutual Fund sold 210,237 shares
- Stake reduced from 9.1667% to 7.1241%
- Holding after sale: 13,854,108 shares
- Q1 FY27 net profit: ₹125 crore, up 31% YoY
- Q1 FY27 total income: ₹1,035 crore versus ₹969 crore
Why this matters
For Tata Chemicals, Rallis’s stronger profitability reinforces the strategic value of its agri-inputs subsidiary, though the stake sale does not indicate a corporate-action trigger.
What to watch
- Confirmation that SBI Mutual Fund's stake sale has concluded
- Q2 margin expansion or contraction versus Q1
- Monsoon progress and acreage data for key crop regions
- Raw-material and agrochemical price movements
- Management guidance upgrades, order/seasonal-demand commentary, or analyst estimate revisions
- Further promoter or institutional stake changes
- Track management commentary on crop-protection volumes, seed demand, pricing and gross-margin drivers.
- Monitor whether SBI Mutual Fund continues selling and whether bulk/block-deal disclosures identify replacement institutional holders.
- Watch kharif rainfall distribution, rural liquidity and farmer planting trends, which can affect agri-input offtake.
- Compare Q2 revenue growth, EBITDA margin and working-capital movement against the Q1 profit increase.
- Assess Tata Chemicals' capital-allocation and strategic commentary for any implications for its Rallis India holding.